Welcome to our dedicated page for Currenc Group Ordinary Shares news (Ticker: CURR), a resource for investors and traders seeking the latest updates and insights on Currenc Group Ordinary Shares stock.
CURE PHARMACEUTICAL HOLDING COR (symbol: CURR), now known as Avenir Wellness Solutions, Inc., is at the forefront of innovative drug delivery and development. The company is dedicated to enhancing drug efficacy, safety, and the overall patient experience through its proprietary drug dosage forms and delivery systems. Avenir boasts an industry-leading full-service CGMP manufacturing facility and is renowned for its advanced oral thin film, Curefilm™, the most sophisticated oral thin film available today.
With a strong presence in the pharmaceutical cannabis sector and partnerships in the U.S., Canada, Israel, and Germany, Avenir is committed to improving how medicines are delivered and experienced worldwide. The company has developed a broad range of products using cutting-edge delivery platforms and collaborates with leading pharmaceutical companies.
Recently, Avenir has experienced significant growth, as evidenced by its financial performance. In the first quarter of 2023, the company reported a 15.1% increase in net revenue year-over-year and a 35.6% sequential increase from Q4 2022, reaching $1.2 million. Gross margins improved by 102 basis points to 78.9%, with further increases expected.
The company's strategic initiatives, including cost reductions and operating leverage, are expected to help narrow the net operating loss from continuing operations, excluding non-cash charges. Avenir's advertising and marketing campaigns, especially for its new product, DNA Complex, have garnered positive attention from prominent media outlets.
On August 9, 2023, the company officially changed its ticker symbol to AVRW and its corporate name to Avenir Wellness Solutions, reflecting its renewed focus on wellness technologies and high-margin products. The rebranding aligns with Avenir's long-term growth strategy to increase revenue through product development, strategic partnerships, and geographic licensing deals.
For more information, visit the company's website at avenirwellness.com.
CURRENC Group Inc. (CURR) reported Q3 2024 financial results with Total Processing Value (TPV) of US$1.21 billion, up 6.1% year-over-year. Total revenues decreased 11.0% to US$11.3 million due to declines in global airtime and remittance revenues. The company reported a net loss of US$5.0 million, increasing 31.6% year-over-year. After divesting TNG Asia and GEA in Q3, CURRENC will focus on Tranglo's remittance and global airtime businesses, along with WalletKu's Indonesian airtime business. Adjusted EBITDA loss narrowed to US$0.2 million, an 83.3% improvement from Q3 2023.
CURRENC Group Inc. (Nasdaq: CURR), a fintech and digital remittance company, celebrated its recent Nasdaq listing with a Closing Bell Ceremony at Nasdaq MarketSite in Times Square. The company, which began trading on Nasdaq on September 3, 2024, completed a business combination with INFINT Acquisition
CURRENC, founded in 2013, focuses on serving unbanked and underbanked individuals in Southeast Asia and beyond. In 2023, the company processed approximately 11 million transactions totaling US$4.54 billion, a 28% increase from 2022. CURRENC's network includes over one million unique users, more than 5,000 bank partners, and coverage across 150 countries.
The public listing is expected to support CURRENC's international growth strategy and help scale its platform to drive progress in the global financial landscape.
Avenir Wellness Solutions (OTCQB: CURR) is set to present at the Planet MicroCap Showcase on April 26, 2023, at 1:30 PM PT (4:30 PM ET). CEO Nancy Duitch will unveil the company's new identity and rebranding strategy, highlighting a high-margin revenue growth plan and ongoing product development. Following a $20 million non-dilutive deal, the company's leadership has focused on enhancing stockholder value through proprietary technology aimed at improving product efficacy and consumer experience. Investors can register to view the presentation virtually. Avenir Wellness is known for its innovative wellness solutions and holds 15 patents for its unique delivery systems. Find further details and updates at www.avenirwellness.com.
Avenir Wellness Solutions, Inc. (OTCQB: CURR) has announced key developments aimed at driving growth in 2023. The company has extended its advertising contract with theSkimm, targeting its audience of over 7 million loyal subscribers to boost sales. The recently launched DNA Complex serum, endorsed by actress Nicole Kidman, has achieved a 77% subscription retention rate, indicating strong consumer approval. In another stride, Avenir has engaged Urish Popeck & Co., LLC as its new independent auditor to enhance financial oversight. Additionally, a new marketing campaign is set to ramp up sales via Amazon and other major retailers, further solidifying the company's market presence. With 15 patents and plans for new product lines, Avenir Wellness is optimistic about significant growth opportunities in the wellness sector throughout the year.
Avenir Wellness Solutions (OTCQB: CURR) announced the launch of its latest skincare innovation, the DNA Complex, under its subsidiary The Sera Labs. This new instant anti-aging serum utilizes Deep Nano Active technology to penetrate the skin deeply, promising immediate wrinkle reduction and long-term effects. The product was celebrated during its debut on the Oscars red carpet, aided by strategic ambassador Nicole Kidman. Retailing at $79.99, DNA Complex aims to redefine skincare with scientifically advanced ingredients that enhance collagen synthesis and skin appearance.
Avenir Wellness Solutions, Inc. (OTCQB:CURR) has announced a partnership with theSkimm social media platform, featuring its brand ambassador Nicole Kidman. The collaboration has resulted in significant month-over-month performance improvements for January 2023, including a 60% increase in online sales and a 2200 rise in social media followers. The company has also launched a new corporate website as part of its rebranding efforts. This initiative aims to enhance shareholder value and promote its innovative wellness technologies.
FAQ
What is the current stock price of Currenc Group Ordinary Shares (CURR)?
What is the market cap of Currenc Group Ordinary Shares (CURR)?
What does Cure Pharmaceutical Holding Corp. do?
What is Curefilm™?
What are the financial highlights for the first quarter of 2023?
What recent changes has Avenir made to its corporate structure?
What is Avenir's mission?
How has Avenir's marketing strategy impacted their business?
What markets does Avenir operate in?
Who are Avenir's notable partners?
What is the significance of the name change to Avenir Wellness Solutions?
Where can I find more information about Avenir's financial performance?
